Jump to content

GV (nerve agent): Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Corrections to IUPAC name in the beginning
formating
Line 6: Line 6:
| ImageFile1 =
| ImageFile1 =
| ImageName1 = Ball-and-stick model of GV
| ImageName1 = Ball-and-stick model of GV
| IUPACName = 2-(Dimethylamino)ethyl N,N-dimethylphosphoroamidofluoridate
| IUPACName = 2-(Dimethylamino)ethyl ''N'',''N''-dimethylphosphoroamidofluoridate
| Section1 = {{Chembox Identifiers
| Section1 = {{Chembox Identifiers
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
Line 30: Line 30:
}}
}}


'''GV''' ([[IUPAC]] name: 2-(Dimethylamino)ethyl ''N'',''N''-dimethylphosphoramidofluoridate) is an [[organophosphate]] [[nerve agent]]. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent [[acetylcholinesterase]] inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as [[atropine]], [[benactyzine]], [[obidoxime]] and [[HI-6]].<ref>Fusek J, Bajgar J. Treatment of intoxication with GV compound in laboratory rats. ''Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity v Hradci Kralove''. 1994;37(2):57-62. PMID 7784799</ref><ref>Kassa J, Bajgar J. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice. ''Acta Medica (Hradec Kralove)''. 1996;39(1):27-30. PMID 9106387</ref>
'''GV''' ([[IUPAC]] name: '''2-(Dimethylamino)ethyl ''N'',''N''-dimethylphosphoramidofluoridate''') is an [[organophosphate]] [[nerve agent]]. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent [[acetylcholinesterase]] inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as [[atropine]], [[benactyzine]], [[obidoxime]] and [[HI-6]].<ref>Fusek J, Bajgar J. Treatment of intoxication with GV compound in laboratory rats. ''Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity v Hradci Kralove''. 1994;37(2):57-62. PMID 7784799</ref><ref>Kassa J, Bajgar J. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice. ''Acta Medica (Hradec Kralove)''. 1996;39(1):27-30. PMID 9106387</ref>


==References==
==References==

Revision as of 20:32, 19 February 2011

GV (nerve agent)
Skeletal formula of GV
Names
IUPAC name
2-(Dimethylamino)ethyl N,N-dimethylphosphoroamidofluoridate
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C6H16FN2OP/c1-8(2)5-6-11(7,10)9(3)4/h5-6H2,1-4H3 checkY
    Key: JJHAGEZAXYOCMC-UHFFFAOYSA-N checkY
  • InChI=1/C6H16FN2OP/c1-8(2)5-6-11(7,10)9(3)4/h5-6H2,1-4H3
    Key: JJHAGEZAXYOCMC-UHFFFAOYAS
  • FP(=O)(N(C)C)CCN(C)C
Properties
C6H16FN2O2P
Molar mass 198.176 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

GV (IUPAC name: 2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate) is an organophosphate nerve agent. GV is a part of a new series of nerve agents with properties similar to both the "G-series" and "V-series". It is a potent acetylcholinesterase inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as atropine, benactyzine, obidoxime and HI-6.[1][2]

References

  1. ^ Fusek J, Bajgar J. Treatment of intoxication with GV compound in laboratory rats. Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity v Hradci Kralove. 1994;37(2):57-62. PMID 7784799
  2. ^ Kassa J, Bajgar J. Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice. Acta Medica (Hradec Kralove). 1996;39(1):27-30. PMID 9106387

See also